Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

[1]  C. Grines,et al.  Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. , 2007, Journal of the American College of Cardiology.

[2]  F. Barry,et al.  Cardiovascular gene therapy: current status and therapeutic potential , 2007, British journal of pharmacology.

[3]  Seppo Ylä-Herttuala,et al.  Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. , 2007, Journal of the American College of Cardiology.

[4]  T. Wirth,et al.  Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy. , 2006, Current drug safety.

[5]  D. Stewart,et al.  Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment , 2006, Gene Therapy.

[6]  A. Smit,et al.  Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. , 2006, Human Gene Therapy.

[7]  K. Alitalo,et al.  Gene Transfers of Vascular Endothelial Growth Factor-A, Vascular Endothelial Growth Factor-B, Vascular Endothelial Growth Factor-C, and Vascular Endothelial Growth Factor-D Have No Effects on Atherosclerosis in Hypercholesterolemic Low-Density Lipoprotein-Receptor/Apolipoprotein B48-Deficient Mice , 2005, Circulation.

[8]  A. Gaggar,et al.  Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity , 2005, Journal of Virology.

[9]  H. Bøtker,et al.  Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. , 2005, Journal of the American College of Cardiology.

[10]  J. Hartikainen,et al.  Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart , 2004, Circulation.

[11]  Craig Pratt,et al.  A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. , 2003, Journal of the American College of Cardiology.

[12]  J. Hartikainen,et al.  Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.

[13]  K. Alitalo,et al.  Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.

[14]  S. Ylä-Herttuala,et al.  Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  S. Ylä-Herttuala,et al.  Cardiovascular gene therapy , 2000, The Lancet.

[16]  S. Durham,et al.  Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial , 1999, The Lancet.

[17]  S. Ylä-Herttuala,et al.  Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. , 1998, Human gene therapy.

[18]  J. Hartikainen,et al.  Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. , 1998, Human gene therapy.

[19]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[20]  M. Laakso,et al.  VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. , 1997, Human gene therapy.

[21]  E. Donetti,et al.  Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. , 1997, Human gene therapy.